RVMD Officer Files Intent to Sell $203K in Company Stock
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
RVMD Officer Files Intent to Sell $203K in Company Stock
Company: Revolution Medicines, Inc. (RVMD) Form: 144 | Filed: 2025-12-12 Significance: Low
Insider: Jeff Cislini Title: Officer | Relationship: Officer
Transaction (Proposed): • Type: Sale • Shares: 2,614 • Approx. Price: $77.81 • Value: $203,395.34
Key Insight: An officer filed a notice of intent to sell a small amount of stock, representing a negligible fraction (<0.002%) of the company's market cap and shares outstanding.
Market Context: This routine sale is planned under a 10b5-1 trading plan adopted in May 2023, indicating it was pre-scheduled and not based on recent events. The transaction size is immaterial.
Comprehensive Analysis
SEC Filing Analysis: Revolution Medicines, Inc. (RVMD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Revolution Medicines has filed a notice of intent to sell approximately $203k worth of common stock.
- Market Impact: The transaction is immaterial, representing a negligible percentage of the company's market capitalization and shares outstanding. No significant market impact is expected.
Company Information
| Field | Value |
|---|---|
| Company | Revolution Medicines, Inc. |
| Ticker Symbol | RVMD |
| CIK | 0001628171 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Jeff Cislini |
| CIK | 0001969082 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-12-15 (Approximate) |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 2,614 |
| Price Per Share | $77.81 (Approximate) |
| Total Value | $203,395.34 |
| Shares Owned After | Not specified |
| Ownership Type | Not specified |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $203,395.34 |
| % of Market Cap | 0.0016% |
| Shares Transacted | 2,614 |
| % of Shares Outstanding | 0.0014% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The proposed sale of $203k is insignificant when compared to Revolution Medicines' market capitalization of $13.10 billion.
- Transaction Significance: The transaction is well below thresholds for significance. The value is less than 0.1% of the market cap, and the shares involved are less than 0.1% of the total shares outstanding (193,319,805), categorizing this as a low-significance event.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a routine Form 144 filing for a small, pre-planned sale by an insider. The size of the transaction is too small to influence market sentiment or stock price.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is a tiny fraction of typical daily trading volume.
- Sentiment Indicator: Neutral. The market generally disregards such small, planned sales from insiders for personal financial management.
Additional Context
Transaction Notes
- Special Circumstances: The sale is being made pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2023. This indicates the decision to sell was made well in advance and is not based on any current, non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.